{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:32:09Z","timestamp":1791221529621,"version":"4.1.0"},"reference-count":122,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2021]]},"DOI":"10.1620\/tjem.254.1","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T22:11:15Z","timestamp":1621375875000},"page":"1-15","source":"Crossref","is-referenced-by-count":20,"title":["Pathology of Aldosterone Biosynthesis and its Action"],"prefix":"10.1620","volume":"254","author":[{"given":"Xin","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Pathology, Tohoku University, Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tohoku University, Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Tezuka","sequence":"additional","affiliation":[{"name":"Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine"},{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Omata","sequence":"additional","affiliation":[{"name":"Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine"},{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikiyo","family":"Ono","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pathology and Histotechnology, Tohoku University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitoshi","family":"Satoh","sequence":"additional","affiliation":[{"name":"Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine"},{"name":"Division of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tohoku University, Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Ames, M.K., Atkins, C.E. &amp; Pitt, B. (2019)  The renin-angiotensin-aldosterone system and its suppression.  <i>J. Vet. Intern. Med.<\/i>, 33, 363-382.","DOI":"10.1111\/jvim.15454"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Arai, K., Morikawa, Y., Ubukata, N., Tsuruoka, H. &amp; Homma, T. (2016)  CS-3150, a novel nonsteroidal mineralocorticoid receptor antagonist, shows preventive and therapeutic effects on renal injury in deoxycorticosterone acetate\/salt-induced hypertensive rats.  <i>J. Pharmacol. Exp. Ther.<\/i>, 358, 548-557.","DOI":"10.1124\/jpet.116.234765"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Arima, S., Kohagura, K., Xu, H.L., Sugawara, A., Uruno, A., Satoh, F., Takeuchi, K. &amp; Ito, S. (2004)  Endothelium-derived nitric oxide modulates vascular action of aldosterone in renal arteriole.  <i>Hypertension<\/i>, 43, 352-357.","DOI":"10.1161\/01.HYP.0000111138.78714.1a"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Arriza, J.L., Weinberger, C., Cerelli, G., Glaser, T.M., Handelin, B.L., Housman, D.E. &amp; Evans, R.M. (1987)  Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.  <i>Science<\/i>, 237, 268-275.","DOI":"10.1126\/science.3037703"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Azizan, E.A., Poulsen, H., Tuluc, P., Zhou, J., Clausen, M.V., Lieb, A., Maniero, C., Garg, S., Bochukova, E.G., Zhao, W., Shaikh, L.H., Brighton, C.A., Teo, A.E., Davenport, A.P., Dekkers, T., et al.  (2013)  Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.  <i>Nat. Genet.<\/i>, 45, 1055-1060.","DOI":"10.1038\/ng.2716"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Barfacker, L., Kuhl, A., Hillisch, A., Grosser, R., Figueroa-Perez, S., Heckroth, H., Nitsche, A., Erguden, J.K., Gielen-Haertwig, H., Schlemmer, K.H., Mittendorf, J., Paulsen, H., Platzek, J. &amp; Kolkhof, P. (2012)  Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases.  <i>ChemMedChem<\/i>, 7, 1385-1403.","DOI":"10.1002\/cmdc.201200081"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Barrera-Chimal, J., Perez-Villalva, R., Ortega, J.A., Sanchez, A., Rodriguez-Romo, R., Durand, M., Jaisser, F. &amp; Bobadilla, N.A. (2015)  Mild ischemic injury leads to long-term alterations in the kidney: amelioration by spironolactone administration.  <i>Int. J. Biol. Sci.<\/i>, 11, 892-900.","DOI":"10.7150\/ijbs.11729"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Barrera-Chimal, J., Perez-Villalva, R., Rodriguez-Romo, R., Reyna, J., Uribe, N., Gamba, G. &amp; Bobadilla, N.A. (2013)  Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury.  <i>Kidney Int.<\/i>, 83, 93-103.","DOI":"10.1038\/ki.2012.352"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Barrett, P.Q., Lu, H.K., Colbran, R., Czernik, A. &amp; Pancrazio, J.J. (2000)  Stimulation of unitary T-type Ca(2+) channel currents by calmodulin-dependent protein kinase II.  <i>Am. J. Physiol. Cell Physiol.<\/i>, 279, C1694-1703.","DOI":"10.1152\/ajpcell.2000.279.6.C1694"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Bauersachs, J., Jaisser, F. &amp; Toto, R. (2015)  Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases.  <i>Hypertension<\/i>, 65, 257-263.","DOI":"10.1161\/HYPERTENSIONAHA.114.04488"},{"key":"11","unstructured":"Bollag, W.B. (2014)  Regulation of aldosterone synthesis and secretion.  <i>Compr. Physiol<\/i>, 4, 1017-1055."},{"key":"12","doi-asserted-by":"crossref","unstructured":"Bomback, A.S., Kshirsagar, A.V., Amamoo, M.A. &amp; Klemmer, P.J. (2008)  Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review.  <i>Am. J. Kidney Dis.<\/i>, 51, 199-211.","DOI":"10.1053\/j.ajkd.2007.10.040"},{"key":"13","unstructured":"Booth, R.E., Johnson, J.P. &amp; Stockand, J.D. (2002)  Aldosterone.  <i>Adv. Physiol. Educ.<\/i>, 26, 8-20."},{"key":"14","unstructured":"Brilla, C.G., Pick, R., Tan, L.B., Janicki, J.S. &amp; Weber, K.T. (1990)  Remodeling of the rat right and left ventricles in experimental hypertension.  <i>Circ. Res.<\/i>, 67, 1355-1364."},{"key":"15","unstructured":"Brown, C.A., Rissi, D.R., Dickerson, V.M., Davis, A.M., Brown, S.A. &amp; Schmiedt, C.W. (2019)  Chronic Renal Changes After a Single Ischemic Event in an Experimental Model of Feline Chronic Kidney Disease.  <i>Vet. Pathol.<\/i>, 56, 536-543."},{"key":"16","doi-asserted-by":"crossref","unstructured":"Brown, J.M., Robinson-Cohen, C., Luque-Fernandez, M.A., Allison, M.A., Baudrand, R., Ix, J.H., Kestenbaum, B., de Boer, I.H. &amp; Vaidya, A. (2017)  The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study.  <i>Ann. Intern. Med.<\/i>, 167, 630-641.","DOI":"10.7326\/M17-0882"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Brown, R.W., Chapman, K.E., Murad, P., Edwards, C.R. &amp; Seckl, J.R. (1996a)  Purification of 11 beta-hydroxysteroid dehydrogenase type 2 from human placenta utilizing a novel affinity labelling technique.  <i>Biochem. J.<\/i>, 313, 997-1005.","DOI":"10.1042\/bj3130997"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Brown, R.W., Diaz, R., Robson, A.C., Kotelevtsev, Y.V., Mullins, J.J., Kaufman, M.H. &amp; Seckl, J.R. (1996b)  The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development.  <i>Endocrinology<\/i>, 137, 794-797.","DOI":"10.1210\/endo.137.2.8593833"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Bujalska, I.J., Walker, E.A., Hewison, M. &amp; Stewart, P.M. (2002)  A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells.  <i>J. Clin. Endocrinol. Metab.<\/i>, 87, 1205-1210.","DOI":"10.1210\/jcem.87.3.8301"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Chang, J., Xue, M., Yang, S., Yao, B., Zhang, B., Chen, X., Pozzi, A. &amp; Zhang, M.Z. (2015)  Inhibition of 11beta-hydroxysteroid dehydrogenase type II suppresses lung carcinogenesis by blocking tumor COX-2 expression as well as the ERK and mTOR signaling pathways.  <i>PLoS One<\/i>, 10, e0127030.","DOI":"10.1371\/journal.pone.0127030"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Choi, M., Scholl, U.I., Yue, P., Bjorklund, P., Zhao, B., Nelson-Williams, C., Ji, W., Cho, Y., Patel, A., Men, C.J., Lolis, E., Wisgerhof, M.V., Geller, D.S., Mane, S., Hellman, P., et al.  (2011)  K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.  <i>Science<\/i>, 331, 768-772.","DOI":"10.1126\/science.1198785"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Coirini, H., Magarinos, A.M., De Nicola, A.F., Rainbow, T.C. &amp; McEwen, B.S. (1985)  Further studies of brain aldosterone binding sites employing new mineralocorticoid and glucocorticoid receptor markers in vitro.  <i>Brain Res.<\/i>, 361, 212-216.","DOI":"10.1016\/0006-8993(85)91291-0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Cowgill, L.D., Polzin, D.J., Elliott, J., Nabity, M.B., Segev, G., Grauer, G.F., Brown, S., Langston, C. &amp; van Dongen, A.M. (2016)  Is progressive chronic kidney disease a slow acute kidney injury? <i>Vet. Clin. North Am. Small Anim. Pract.<\/i>, 46, 995-1013.","DOI":"10.1016\/j.cvsm.2016.06.001"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Danforth, D.N.  Jr., Orlando, M.M., Bartter, F.C. &amp; Javadpour, N. (1977)  Renal changes in primary aldosteronism.  <i>J. Urol.<\/i>, 117, 140-144.","DOI":"10.1016\/S0022-5347(17)58376-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"De Sousa, K., Boulkroun, S., Baron, S., Nanba, K., Wack, M., Rainey, W.E., Rocha, A., Giscos-Douriez, I., Meatchi, T., Amar, L., Travers, S., Fernandes-Rosa, F.L. &amp; Zennaro, M.C. (2020)  Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma.  <i>Hypertension<\/i>, 75, 1034-1044.","DOI":"10.1161\/HYPERTENSIONAHA.119.14177"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Di Leva, F., Domi, T., Fedrizzi, L., Lim, D. &amp; Carafoli, E. (2008)  The plasma membrane Ca2+ ATPase of animal cells: structure, function and regulation.  <i>Arch. Biochem. Biophys.<\/i>, 476, 65-74.","DOI":"10.1016\/j.abb.2008.02.026"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Duprez, D.A. (2007)  Aldosterone and the vasculature: mechanisms mediating resistant hypertension.  <i>J. Clin. Hypertens. <\/i>(<i>Greenwich<\/i>), 9, 13-18.","DOI":"10.1111\/j.1524-6175.2007.06367.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Edwards, C.R., Stewart, P.M., Burt, D., Brett, L., McIntyre, M.A., Sutanto, W.S., de Kloet, E.R. &amp; Monder, C. (1988)  Localisation of 11 beta-hydroxysteroid dehydrogenase: tissue specific protector of the mineralocorticoid receptor.  <i>Lancet<\/i>, 2, 986-989.","DOI":"10.1016\/S0140-6736(88)90742-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Fern, R.J., Hahm, M.S., Lu, H.K., Liu, L.P., Gorelick, F.S. &amp; Barrett, P.Q. (1995)  Ca2+\/calmodulin-dependent protein kinase II activation and regulation of adrenal glomerulosa Ca2+ signaling.  <i>Am. J. Physiol.<\/i>, 269, F751-760.","DOI":"10.1152\/ajprenal.1995.269.6.F751"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Fernandes-Rosa, F.L., Williams, T.A., Riester, A., Steichen, O., Beuschlein, F., Boulkroun, S., Strom, T.M., Monticone, S., Amar, L., Meatchi, T., Mantero, F., Cicala, M.V., Quinkler, M., Fallo, F., Allolio, B., et al.  (2014)  Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.  <i>Hypertension<\/i>, 64, 354-361.","DOI":"10.1161\/HYPERTENSIONAHA.114.03419"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Funder, J.W. (2012)  The genetics of primary aldosteronism: chapter two.  <i>Hypertension<\/i>, 59, 537-538.","DOI":"10.1161\/HYPERTENSIONAHA.111.187682"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Funder, J.W., Pearce, P.T., Smith, R. &amp; Smith, A.I. (1988)  Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated.  <i>Science<\/i>, 242, 583-585.","DOI":"10.1126\/science.2845584"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Gao, X., Yamazaki, Y., Tezuka, Y., Omata, K., Ono, Y., Morimoto, R., Nakamura, Y., Satoh, F. &amp; Sasano, H. (2021a)  Gender differences in human adrenal cortex and its disorders.  <i>Mol. Cell. Endocrinol.<\/i>, 526, 111177.","DOI":"10.1016\/j.mce.2021.111177"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Gao, X., Yamazaki, Y., Tezuka, Y., Omata, K., Ono, Y., Morimoto, R., Nakamura, Y., Satoh, F. &amp; Sasano, H. (2021b)  The genotype-based morphology of aldosterone-producing adrenocortical disorders and their association with aging.  <i>Endocrinol Metab<\/i> (<i>Seoul<\/i>), 36, 12-21.","DOI":"10.3803\/EnM.2021.101"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Gao, X., Yamazaki, Y., Tezuka, Y., Pieroni, J., Ishii, K., Atsumi, N., Ono, Y., Omata, K., Morimoto, R., Nakamura, Y., Satoh, F. &amp; Sasano, H. (2020)  Intratumoral heterogeneity of the tumor cells based on in situ cortisol excess in cortisol-producing adenomas; approximately an association among morphometry, genotype and cellular senescence approximately.  <i>J. Steroid Biochem. Mol. Biol.<\/i>, 204, 105764.","DOI":"10.1016\/j.jsbmb.2020.105764"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Gomez-Sanchez, C.E., Qi, X., Velarde-Miranda, C., Plonczynski, M.W., Parker, C.R., Rainey, W., Satoh, F., Maekawa, T., Nakamura, Y., Sasano, H. &amp; Gomez-Sanchez, E.P. (2014)  Development of monoclonal antibodies against human CYP11B1 and CYP11B2.  <i>Mol. Cell. Endocrinol.<\/i>, 383, 111-117.","DOI":"10.1016\/j.mce.2013.11.022"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Gray, G.A., White, C.I., Castellan, R.F., McSweeney, S.J. &amp; Chapman, K.E. (2017)  Getting to the heart of intracellular glucocorticoid regeneration: 11beta-HSD1 in the myocardium.  <i>J. Mol. Endocrinol.<\/i>, 58, R1-R13.","DOI":"10.1530\/JME-16-0128"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Gromotowicz, A., Szemraj, J., Stankiewicz, A., Zakrzeska, A., Mantur, M., Jaroszewicz, E., Rogowski, F. &amp; Chabielska, E. (2011)  Study of the mechanisms of aldosterone prothrombotic effect in rats.  <i>J. Renin Angiotensin Aldosterone Syst.<\/i>, 12, 430-439.","DOI":"10.1177\/1470320310397405"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Hattangady, N.G., Olala, L.O., Bollag, W.B. &amp; Rainey, W.E. (2012)  Acute and chronic regulation of aldosterone production.  <i>Mol. Cell. Endocrinol.<\/i>, 350, 151-162.","DOI":"10.1016\/j.mce.2011.07.034"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Hawker, P.C., McKay, J.S. &amp; Turnberg, L.A. (1980)  Electrolyte transport across colonic mucosa from patients with inflammatory bowel disease.  <i>Gastroenterology<\/i>, 79, 508-511.","DOI":"10.1016\/0016-5085(80)90376-5"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Hirasawa, G., Sasano, H., Suzuki, T., Takeyama, J., Muramatu, Y., Fukushima, K., Hiwatashi, N., Toyota, T., Nagura, H. &amp; Krozowski, Z.S. (1999)  11Beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor in human fetal development.  <i>J. Clin. Endocrinol. Metab.<\/i>, 84, 1453-1458.","DOI":"10.1210\/jcem.84.4.5615"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Hirasawa, G., Sasano, H., Takahashi, K., Fukushima, K., Suzuki, T., Hiwatashi, N., Toyota, T., Krozowski, Z.S. &amp; Nagura, H. (1997)  Colocalization of 11 beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human epithelia.  <i>J. Clin. Endocrinol. Metab.<\/i>, 82, 3859-3863.","DOI":"10.1210\/jcem.82.11.4337"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Hirasawa, G., Takeyama, J., Sasano, H., Fukushima, K., Suzuki, T., Muramatu, Y., Darnel, A.D., Kaneko, C., Hiwatashi, N., Toyota, T., Nagura, H. &amp; Krozowski, Z.S. (2000)  11Beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human placenta.  <i>J. Clin. Endocrinol. Metab.<\/i>, 85, 1306-1309.","DOI":"10.1210\/jcem.85.3.6429"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Hollenberg, N.K. (2004)  Aldosterone in the development and progression of renal injury.  <i>Kidney Int.<\/i>, 66, 1-9.","DOI":"10.1111\/j.1523-1755.2004.00701.x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Horiuchi, M., Akishita, M. &amp; Dzau, V.J. (1999)  Recent progress in angiotensin II type 2 receptor research in the cardiovascular system.  <i>Hypertension<\/i>, 33, 613-621.","DOI":"10.1161\/01.HYP.33.2.613"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Itoh, H., Ito, S., Rakugi, H., Okuda, Y. &amp; Nishioka, S. (2019)  Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study.  <i>Hypertens. Res.<\/i>, 42, 1572-1581.","DOI":"10.1038\/s41440-019-0270-2"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Iwakura, Y., Morimoto, R., Kudo, M., Ono, Y., Takase, K., Seiji, K., Arai, Y., Nakamura, Y., Sasano, H., Ito, S. &amp; Satoh, F. (2014)  Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases.  <i>J. Clin. Endocrinol. Metab.<\/i>, 99, 1593-1598.","DOI":"10.1210\/jc.2013-2180"},{"key":"48","unstructured":"Kato, K., Sasano, H., Ohara, S., Sekine, H., Mochizuki, S., Mune, T., Yasuda, K., Nagura, H., Shimosegawa, T., Toyota, T. &amp; Krozowski, Z. (1999)  Coexpression of mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenase 2 in human gastric mucosa.  <i>J. Clin. Endocrinol. Metab.<\/i>, 84, 2568-2573."},{"key":"49","unstructured":"Kitamoto, T., Suematsu, S., Matsuzawa, Y., Saito, J., Omura, M. &amp; Nishikawa, T. (2015)  Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas.  <i>J. Atheroscler. Thromb.<\/i>, 22, 191-200."},{"key":"50","unstructured":"Kitamoto, T., Suematsu, S., Yamazaki, Y., Nakamura, Y., Sasano, H., Matsuzawa, Y., Saito, J., Omura, M. &amp; Nishikawa, T. (2016)  Clinical and Steroidogenic Characteristics of Aldosterone-Producing Adenomas With ATPase or CACNA1D Gene Mutations.  <i>J. Clin. Endocrinol. Metab.<\/i>, 101, 494-503."},{"key":"51","unstructured":"Koenig, J.B. &amp; Jaffe, I.Z. (2014)  Direct role for smooth muscle cell mineralocorticoid receptors in vascular remodeling: novel mechanisms and clinical implications.  <i>Curr. Hypertens. Rep.<\/i>, 16, 427."},{"key":"52","unstructured":"Konishi, A., Tazawa, C., Miki, Y., Darnel, A.D., Suzuki, T., Ohta, Y., Suzuki, T., Tabayashi, K. &amp; Sasano, H. (2003)  The possible roles of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in cardiac fibrosis in the spontaneously hypertensive rat.  <i>J. Steroid Biochem. Mol. Biol.<\/i>, 85, 439-442."},{"key":"53","unstructured":"Krozowski, Z.S. &amp; Funder, J.W. (1983)  Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity.  <i>Proc. Natl. Acad. Sci. U. S. A.<\/i>, 80, 6056-6060."},{"key":"54","doi-asserted-by":"crossref","unstructured":"Lai, L., Chen, J., Hao, C.M., Lin, S. &amp; Gu, Y. (2006)  Aldosterone promotes fibronectin production through a Smad2-dependent TGF-beta1 pathway in mesangial cells.  <i>Biochem. Biophys. Res. Commun.<\/i>, 348, 70-75.","DOI":"10.1016\/j.bbrc.2006.07.057"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Laragh, J.H., Baer, L., Brunner, H.R., Buhler, F.R., Sealey, J.E. &amp; Vaughan, E.D.Jr. (1972)  Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease.  <i>Am. J. Med.<\/i>, 52, 633-652.","DOI":"10.1016\/0002-9343(72)90054-X"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Laragh, J.H. &amp; Sealey, J.E. (2011)  The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure.  <i>Am. J. Hypertens.<\/i>, 24, 1164-1180.","DOI":"10.1038\/ajh.2011.171"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Lavall, D., Selzer, C., Schuster, P., Lenski, M., Adam, O., Schafers, H.J., Bohm, M. &amp; Laufs, U. (2014)  The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation.  <i>J. Biol. Chem.<\/i>, 289, 6656-6668.","DOI":"10.1074\/jbc.M113.519256"},{"key":"58","doi-asserted-by":"crossref","unstructured":"Levitan, R. &amp; Ingelfinger, F.J. (1965)  Effect of D-Aldosterone on Salt and Water Absorption from the Intact Human Colon.  <i>J. Clin. Invest.<\/i>, 44, 801-808.","DOI":"10.1172\/JCI105192"},{"key":"59","doi-asserted-by":"crossref","unstructured":"Li, L., Guan, Y., Kobori, H., Morishita, A., Kobara, H., Masaki, T., Nakano, D. &amp; Nishiyama, A. (2019)  Effects of the novel nonsteroidal mineralocorticoid receptor blocker, esaxerenone (CS-3150), on blood pressure and urinary angiotensinogen in low-renin Dahl salt-sensitive hypertensive rats.  <i>Hypertens. Res.<\/i>, 42, 769-778.","DOI":"10.1038\/s41440-018-0187-1"},{"key":"60","doi-asserted-by":"crossref","unstructured":"McCurley, A., McGraw, A., Pruthi, D. &amp; Jaffe, I.Z. (2013)  Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease.  <i>Pflugers Arch.<\/i>, 465, 1661-1670.","DOI":"10.1007\/s00424-013-1282-4"},{"key":"61","doi-asserted-by":"crossref","unstructured":"Mercer, W., Obeyesekere, V., Smith, R. &amp; Krozowski, Z. (1993)  Characterization of 11 beta-HSD1B gene expression and enzymatic activity.  <i>Mol. Cell. Endocrinol.<\/i>, 92, 247-251.","DOI":"10.1016\/0303-7207(93)90015-C"},{"key":"62","doi-asserted-by":"crossref","unstructured":"Moguilewsky, M. &amp; Raynaud, J.P. (1980)  Evidence for a specific mineralocorticoid receptor in rat pituitary and brain.  <i>J. Steroid Biochem.<\/i>, 12, 309-314.","DOI":"10.1016\/0022-4731(80)90285-X"},{"key":"63","doi-asserted-by":"crossref","unstructured":"Nakamura, Y., Maekawa, T., Felizola, S.J., Satoh, F., Qi, X., Velarde-Miranda, C., Plonczynski, M.W., Ise, K., Kikuchi, K., Rainey, W.E., Gomez-Sanchez, E.P., Gomez-Sanchez, C.E. &amp; Sasano, H. (2014)  Adrenal CYP11B1\/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies.  <i>Mol. Cell. Endocrinol.<\/i>, 392, 73-79.","DOI":"10.1016\/j.mce.2014.05.002"},{"key":"64","doi-asserted-by":"crossref","unstructured":"Nakamura, Y., Suzuki, S., Suzuki, T., Ono, K., Miura, I., Satoh, F., Moriya, T., Saito, H., Yamada, S., Ito, S. &amp; Sasano, H. (2006)  MDM2: a novel mineralocorticoid-responsive gene involved in aldosterone-induced human vascular structural remodeling.  <i>Am. J. Pathol.<\/i>, 169, 362-371.","DOI":"10.2353\/ajpath.2006.051351"},{"key":"65","doi-asserted-by":"crossref","unstructured":"Nakamura, Y., Yamazaki, Y., Tezuka, Y., Satoh, F. &amp; Sasano, H. (2016)  Expression of CYP11B2 in aldosterone-producing adrenocortical adenoma: regulatory mechanisms and clinical significance.  <i>Tohoku J. Exp. Med.<\/i>, 240, 183-190.","DOI":"10.1620\/tjem.240.183"},{"key":"66","doi-asserted-by":"crossref","unstructured":"Nanba, K., Tsuiki, M., Sawai, K., Mukai, K., Nishimoto, K., Usui, T., Tagami, T., Okuno, H., Yamamoto, T., Shimatsu, A., Katabami, T., Okumura, A., Kawa, G., Tanabe, A. &amp; Naruse, M. (2013)  Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry.  <i>J. Clin. Endocrinol. Metab.<\/i>, 98, 1567-1574.","DOI":"10.1210\/jc.2012-3726"},{"key":"67","doi-asserted-by":"crossref","unstructured":"Nanba, K., Vaidya, A., Williams, G.H., Zheng, I., Else, T. &amp; Rainey, W.E. (2017)  Age-related autonomous aldosteronism.  <i>Circulation<\/i>, 136, 347-355.","DOI":"10.1161\/CIRCULATIONAHA.117.028201"},{"key":"68","doi-asserted-by":"crossref","unstructured":"Nangaku, M. (2006)  Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.  <i>J. Am. Soc. Nephrol.<\/i>, 17, 17-25.","DOI":"10.1681\/ASN.2005070757"},{"key":"69","doi-asserted-by":"crossref","unstructured":"Nishimoto, K., Nakagawa, K., Li, D., Kosaka, T., Oya, M., Mikami, S., Shibata, H., Itoh, H., Mitani, F., Yamazaki, T., Ogishima, T., Suematsu, M. &amp; Mukai, K. (2010)  Adrenocortical zonation in humans under normal and pathological conditions.  <i>J. Clin. Endocrinol. Metab.<\/i>, 95, 2296-2305.","DOI":"10.1210\/jc.2009-2010"},{"key":"70","doi-asserted-by":"crossref","unstructured":"Nishimoto, K., Tomlins, S.A., Kuick, R., Cani, A.K., Giordano, T.J., Hovelson, D.H., Liu, C.J., Sanjanwala, A.R., Edwards, M.A., Gomez-Sanchez, C.E., Nanba, K. &amp; Rainey, W.E. (2015)  Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.  <i>Proc. Natl. Acad. Sci. U. S. A.<\/i>, 112, E4591-4599.","DOI":"10.1073\/pnas.1505529112"},{"key":"71","doi-asserted-by":"crossref","unstructured":"Oberleithner, H., Ludwig, T., Riethmuller, C., Hillebrand, U., Albermann, L., Schafer, C., Shahin, V. &amp; Schillers, H. (2004)  Human endothelium: target for aldosterone.  <i>Hypertension<\/i>, 43, 952-956.","DOI":"10.1161\/01.HYP.0000123572.45556.a5"},{"key":"72","unstructured":"Olivera, W.G., Ciccolella, D.E., Barquin, N., Ridge, K.M., Rutschman, D.H., Yeates, D.B. &amp; Sznajder, J.I. (2000)  Aldosterone regulates Na,K-ATPase and increases lung edema clearance in rats.  <i>Am. J. Respir. Crit. Care Med.<\/i>, 161, 567-573."},{"key":"73","unstructured":"Omata, K., Anand, S.K., Hovelson, D.H., Liu, C.J., Yamazaki, Y., Nakamura, Y., Ito, S., Satoh, F., Sasano, H., Rainey, W.E. &amp; Tomlins, S.A. (2017)  Aldosterone-producing cell clusters frequently harbor somatic mutations and accumulate with age in normal adrenals.  <i>J. Endocr.<\/i><i> Soc.<\/i>, 1, 787-799."},{"key":"74","doi-asserted-by":"crossref","unstructured":"Omata, K., Satoh, F., Morimoto, R., Ito, S., Yamazaki, Y., Nakamura, Y., Anand, S.K., Guo, Z., Stowasser, M., Sasano, H., Tomlins, S.A. &amp; Rainey, W.E. (2018)  Cellular and genetic causes of idiopathic hyperaldosteronism.  <i>Hypertension<\/i>, 72, 874-880.","DOI":"10.1161\/HYPERTENSIONAHA.118.11086"},{"key":"75","unstructured":"Ono, Y., Yamazaki, Y., Omata, K., Else, T., Tomlins, S.A., Rhayem, Y., Williams, T.A., Reincke, M., Carling, T., Monticone, S., Mulatero, P., Beuschlein, F., Ito, S., Satoh, F., Rainey, W.E., et al.   (2019)  Histological characterization of aldosterone-producing adrenocortical adenomas with different somatic mutations.  <i>J. Clin. Endocrinol. Metab.<\/i>, 105, e282-e289."},{"key":"76","unstructured":"Patel, S., Rauf, A., Khan, H. &amp; Abu-Izneid, T. (2017)  Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies.  <i>Biomed. Pharmacother.<\/i>, 94, 317-325."},{"key":"77","doi-asserted-by":"crossref","unstructured":"Pitt, B., Zannad, F., Remme, W.J., Cody, R., Castaigne, A., Perez, A., Palensky, J. &amp; Wittes, J. (1999)  The effect of spironolactone on morbidity and mortality in patients with severe heart failure.  Randomized Aldactone Evaluation Study Investigators.  <i>N. Engl. J. Med.<\/i>, 341, 709-717.","DOI":"10.1056\/NEJM199909023411001"},{"key":"78","doi-asserted-by":"crossref","unstructured":"Pruthi, D., McCurley, A., Aronovitz, M., Galayda, C., Karumanchi, S.A. &amp; Jaffe, I.Z. (2014)  Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors.  <i>Arterioscler. Thromb. Vasc. Biol.<\/i>, 34, 355-364.","DOI":"10.1161\/ATVBAHA.113.302854"},{"key":"79","doi-asserted-by":"crossref","unstructured":"Qin, W., Rudolph, A.E., Bond, B.R., Rocha, R., Blomme, E.A., Goellner, J.J., Funder, J.W. &amp; McMahon, E.G. (2003)  Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.  <i>Circ. Res.<\/i>, 93, 69-76.","DOI":"10.1161\/01.RES.0000080521.15238.E5"},{"key":"80","doi-asserted-by":"crossref","unstructured":"Rachow, T., Schiffl, H. &amp; Lang, S.M. (2021)  Risk of lung cancer and renin-angiotensin blockade: a concise review.  <i>J. Cancer Res. Clin. Oncol.<\/i>, 147, 195-204.","DOI":"10.1007\/s00432-020-03445-x"},{"key":"81","doi-asserted-by":"crossref","unstructured":"Reul, J.M. &amp; de Kloet, E.R. (1985)  Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation.  <i>Endocrinology<\/i>, 117, 2505-2511.","DOI":"10.1210\/endo-117-6-2505"},{"key":"82","doi-asserted-by":"crossref","unstructured":"Rizzoni, D., Porteri, E., Castellano, M., Bettoni, G., Muiesan, M.L., Muiesan, P., Giulini, S.M. &amp; Agabiti-Rosei, E. (1996)  Vascular hypertrophy and remodeling in secondary hypertension.  <i>Hypertension<\/i>, 28, 785-790.","DOI":"10.1161\/01.HYP.28.5.785"},{"key":"83","doi-asserted-by":"crossref","unstructured":"Rocha, R., Rudolph, A.E., Frierdich, G.E., Nachowiak, D.A., Kekec, B.K., Blomme, E.A., McMahon, E.G. &amp; Delyani, J.A. (2002)  Aldosterone induces a vascular inflammatory phenotype in the rat heart.  <i>Am. J. Physiol. Heart Circ. Physiol.<\/i>, 283, H1802-1810.","DOI":"10.1152\/ajpheart.01096.2001"},{"key":"84","doi-asserted-by":"crossref","unstructured":"Rossi, G.P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., Mallamaci, F., Mannelli, M., Mattarello, M.J., Moretti, A., Palumbo, G., et al.  (2006)  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.  <i>J. Am. Coll. Cardiol.<\/i>, 48, 2293-2300.","DOI":"10.1016\/j.jacc.2006.07.059"},{"key":"85","doi-asserted-by":"crossref","unstructured":"Sanchez-Pozos, K., Barrera-Chimal, J., Garzon-Muvdi, J., Perez-Villalva, R., Rodriguez-Romo, R., Cruz, C., Gamba, G. &amp; Bobadilla, N.A. (2012)  Recovery from ischemic acute kidney injury by spironolactone administration.  <i>Nephrol. Dial. Transplant.<\/i>, 27, 3160-3169.","DOI":"10.1093\/ndt\/gfs014"},{"key":"86","doi-asserted-by":"crossref","unstructured":"Sandle, G.I., Higgs, N., Crowe, P., Marsh, M.N., Venkatesan, S. &amp; Peters, T.J. (1990)  Cellular basis for defective electrolyte transport in inflamed human colon.  <i>Gastroenterology<\/i>, 99, 97-105.","DOI":"10.1016\/0016-5085(90)91235-X"},{"key":"87","doi-asserted-by":"crossref","unstructured":"Santos, R.A.S., Sampaio, W.O., Alzamora, A.C., Motta-Santos, D., Alenina, N., Bader, M. &amp; Campagnole-Santos, M.J. (2018)  The ACE2\/Angiotensin-(1-7)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7).  <i>Physiol. Rev.<\/i>, 98, 505-553.","DOI":"10.1152\/physrev.00023.2016"},{"key":"88","doi-asserted-by":"crossref","unstructured":"Sasano, H., Mason, J.I. &amp; Sasano, N. (1989a)  Immunohistochemical study of cytochrome P-45017 alpha in human adrenocortical disorders.  <i>Hum. Pathol.<\/i>, 20, 113-117.","DOI":"10.1016\/0046-8177(89)90174-3"},{"key":"89","doi-asserted-by":"crossref","unstructured":"Sasano, H., Mason, J.L., Sasano, N. &amp; Nagura, H. (1990)  Immunolocalization of 3beta-hydroxysteroid dehydrogenase in human adrenal cortex and in its disorders.  <i>Endocr. Pathol.<\/i>, 1, 94-101.","DOI":"10.1007\/BF02915624"},{"key":"90","doi-asserted-by":"crossref","unstructured":"Sasano, H., Sasano, N. &amp; Okamoto, M. (1989b)  Immunohistochemical demonstration of cholesterol side-chain cleavage cytochrome P-450 in bovine and human adrenals.  <i>Pathol. Res. Pract.<\/i>, 184, 337-342.","DOI":"10.1016\/S0344-0338(89)80096-2"},{"key":"91","doi-asserted-by":"crossref","unstructured":"Sasano, H., Watanabe, N. &amp; Sasano, N. (1986)  Corticosteroid binding in human artery.  <i>Tohoku J. Exp. Med.<\/i>, 150, 117-125.","DOI":"10.1620\/tjem.150.117"},{"key":"92","doi-asserted-by":"crossref","unstructured":"Sasano, H., White, P.C., New, M.I. &amp; Sasano, N. (1988)  Immunohistochemistry of cytochrome P-450 21-hydroxylase: microscopic examination of the enzyme in the bovine adrenal cortex and kidney.  <i>Endocrinology<\/i>, 122, 291-295.","DOI":"10.1210\/endo-122-1-291"},{"key":"93","doi-asserted-by":"crossref","unstructured":"Seccia, T.M., Caroccia, B., Gomez-Sanchez, E.P., Gomez-Sanchez, C.E. &amp; Rossi, G.P. (2018)  The biology of normal zona glomerulosa and aldosterone-producing adenoma: pathological implications.  <i>Endocr. Rev.<\/i>, 39, 1029-1056.","DOI":"10.1210\/er.2018-00060"},{"key":"94","doi-asserted-by":"crossref","unstructured":"Shapiro, J.M., Subedi, S. &amp; LeLeiko, N.S. (2016)  Inflammatory bowel disease.  <i>Pediatr. Rev.<\/i>, 37, 337-347.","DOI":"10.1542\/pir.2015-0110"},{"key":"95","doi-asserted-by":"crossref","unstructured":"Sheppard, K. &amp; Funder, J.W. (1987)  Mineralocorticoid specificity of renal type I receptors: in vivo binding studies.  <i>Am. J. Physiol.<\/i>, 252, E224-229.","DOI":"10.1152\/ajpendo.1987.252.2.E224"},{"key":"96","doi-asserted-by":"crossref","unstructured":"Sheppard, K.E. &amp; Autelitano, D.J. (2002)  11Beta-hydroxysteroid dehydrogenase 1 transforms 11-dehydrocorticosterone into transcriptionally active glucocorticoid in neonatal rat heart.  <i>Endocrinology<\/i>, 143, 198-204.","DOI":"10.1210\/endo.143.1.8583"},{"key":"97","doi-asserted-by":"crossref","unstructured":"Silvestre, J.S., Heymes, C., Oubenaissa, A., Robert, V., Aupetit-Faisant, B., Carayon, A., Swynghedauw, B. &amp; Delcayre, C. (1999)  Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis.  <i>Circulation<\/i>, 99, 2694-2701.","DOI":"10.1161\/01.CIR.99.20.2694"},{"key":"98","doi-asserted-by":"crossref","unstructured":"Sparks, M.A., Crowley, S.D., Gurley, S.B., Mirotsou, M. &amp; Coffman, T.M. (2014)  Classical renin-angiotensin system in kidney physiology.  <i>Compr. Physiol.<\/i>, 4, 1201-1228.","DOI":"10.1002\/cphy.c130040"},{"key":"99","doi-asserted-by":"crossref","unstructured":"Spat, A., Hunyady, L. &amp; Szanda, G. (2016)  Signaling Interactions in the Adrenal Cortex.  <i>Front. Endocrinol. <\/i>(<i>Lausanne<\/i>), 7, 17.","DOI":"10.3389\/fendo.2016.00017"},{"key":"100","doi-asserted-by":"crossref","unstructured":"Spencer, S., Wheeler-Jones, C. &amp; Elliott, J. (2020)  Aldosterone and the mineralocorticoid receptor in renal injury: a potential therapeutic target in feline chronic kidney disease.  <i>J. Vet. Pharmacol. Ther.<\/i>, 43, 243-267.","DOI":"10.1111\/jvp.12848"},{"key":"101","unstructured":"Stewart, P.M., Corrie, J.E., Shackleton, C.H. &amp; Edwards, C.R. (1988)  Syndrome of apparent mineralocorticoid excess.  A defect in the cortisol-cortisone shuttle.  <i>J. Clin. Invest.<\/i>, 82, 340-349."},{"key":"102","doi-asserted-by":"crossref","unstructured":"Stewart, P.M., Wallace, A.M., Valentino, R., Burt, D., Shackleton, C.H. &amp; Edwards, C.R. (1987)  Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.  <i>Lancet<\/i>, 2, 821-824.","DOI":"10.1016\/S0140-6736(87)91014-2"},{"key":"103","unstructured":"Sun, Y., Zhang, J., Lu, L., Chen, S.S., Quinn, M.T. &amp; Weber, K.T. (2002)  Aldosterone-induced inflammation in the rat heart : role of oxidative stress.  <i>Am. J. Pathol.<\/i>, 161, 1773-1781."},{"key":"104","unstructured":"Suzuki, T., Sasano, H., Suzuki, S., Hirasawa, G., Takeyama, J., Muramatsu, Y., Date, F., Nagura, H. &amp; Krozowski, Z.S. (1998)  11Beta-hydroxysteroid dehydrogenase type 2 in human lung: possible regulator of mineralocorticoid action.  <i>J. Clin. Endocrinol. Metab.<\/i>, 83, 4022-4025."},{"key":"105","unstructured":"Takahashi, K., Sasano, H., Fukushima, K., Hirasawa, G., Miura, H., Sasaki, I., Matsuno, S., Krozowski, Z.S. &amp; Nagura, H. (1998)  11 beta-hydroxysteroid dehydrogenase type II in human colon: a new marker of fetal development and differentiation in neoplasms.  <i>Anticancer Res.<\/i>, 18, 3381-3388."},{"key":"106","unstructured":"Takahashi, K.I., Fukushima, K., Sasano, H., Sasaki, I., Matsuno, S., Krozowski, Z.S. &amp; Nagura, H. (1999)  Type II 11beta-hydroxysteroid dehydrogenase expression in human colonic epithelial cells of inflammatory bowel disease.  <i>Dig. Dis. Sci.<\/i>, 44, 2516-2522."},{"key":"107","doi-asserted-by":"crossref","unstructured":"Tannin, G.M., Agarwal, A.K., Monder, C., New, M.I. &amp; White, P.C. (1991)  The human gene for 11 beta-hydroxysteroid dehydrogenase.  Structure, tissue distribution, and chromosomal localization.  <i>J. Biol. Chem.<\/i>, 266, 16653-16658.","DOI":"10.1016\/S0021-9258(18)55351-5"},{"key":"108","doi-asserted-by":"crossref","unstructured":"Toniato, A., Bernante, P., Rossi, G.P. &amp; Pelizzo, M.R. (2006)  The role of adrenal venous sampling in the surgical management of primary aldosteronism.  <i>World J. Surg.<\/i>, 30, 624-627.","DOI":"10.1007\/s00268-005-0482-2"},{"key":"109","doi-asserted-by":"crossref","unstructured":"Tsai, C.T., Chiang, F.T., Tseng, C.D., Hwang, J.J., Kuo, K.T., Wu, C.K., Yu, C.C., Wang, Y.C., Lai, L.P. &amp; Lin, J.L. (2010)  Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.  <i>J. Am. Coll. Cardiol.<\/i>, 55, 758-770.","DOI":"10.1016\/j.jacc.2009.09.045"},{"key":"110","doi-asserted-by":"crossref","unstructured":"Tsuchiyama, H., Kawai, K., Harada, T., Shigematsu, K. &amp; Sugihara, H. (1980)  Functional pathology of aldosterone-producing adenoma.  <i>Acta Pathol. Jpn.<\/i>, 30, 967-976.","DOI":"10.1111\/j.1440-1827.1980.tb03284.x"},{"key":"111","doi-asserted-by":"crossref","unstructured":"Ulick, S., Ramirez, L.C. &amp; New, M.I. (1977)  An abnormality in steroid reductive metabolism in a hypertensive syndrome.  <i>J. Clin. Endocrinol. Metab.<\/i>, 44, 799-802.","DOI":"10.1210\/jcem-44-4-799"},{"key":"112","doi-asserted-by":"crossref","unstructured":"Walker, B.R., Yau, J.L., Brett, L.P., Seckl, J.R., Monder, C., Williams, B.C. &amp; Edwards, C.R. (1991)  11 beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.  <i>Endocrinology<\/i>, 129, 3305-3312.","DOI":"10.1210\/endo-129-6-3305"},{"key":"113","doi-asserted-by":"crossref","unstructured":"Wan, N., Rahman, A. &amp; Nishiyama, A. (2021)  Esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker (MRB) in hypertension and chronic kidney disease.  <i>J. Hum. Hypertens.<\/i>, 35, 148-156.","DOI":"10.1038\/s41371-020-0377-6"},{"key":"114","doi-asserted-by":"crossref","unstructured":"Weber, K.T. &amp; Brilla, C.G. (1991)  Pathological hypertrophy and cardiac interstitium.  Fibrosis and renin-angiotensin-aldosterone system.  <i>Circulation<\/i>, 83, 1849-1865.","DOI":"10.1161\/01.CIR.83.6.1849"},{"key":"115","doi-asserted-by":"crossref","unstructured":"Weinberger, M.H., Roniker, B., Krause, S.L. &amp; Weiss, R.J. (2002)  Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension.  <i>Am. J. Hypertens.<\/i>, 15, 709-716.","DOI":"10.1016\/S0895-7061(02)02957-6"},{"key":"116","doi-asserted-by":"crossref","unstructured":"Williams, J.S., Williams, G.H., Raji, A., Jeunemaitre, X., Brown, N.J., Hopkins, P.N. &amp; Conlin, P.R. (2006)  Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia.  <i>J. Hum. Hypertens.<\/i>, 20, 129-136.","DOI":"10.1038\/sj.jhh.1001948"},{"key":"117","doi-asserted-by":"crossref","unstructured":"Williams, T.A., Gomez-Sanchez, C.E., Rainey, W.E., Giordano, T.J., Lam, A.K., Marker, A., Mete, O., Yamazaki, Y., Zerbini, M.C.N., Beuschlein, F., Satoh, F., Burrello, J., Schneider, H., Lenders, J.W.M., Mulatero, P., et al.   (2021)  International histopathology consensus for unilateral primary aldosteronism.  <i>J. Clin. Endocrinol. Metab.<\/i>, 106, 42-54.","DOI":"10.1210\/clinem\/dgaa484"},{"key":"118","doi-asserted-by":"crossref","unstructured":"Yamazaki, Y., Nakamura, Y., Omata, K., Ise, K., Tezuka, Y., Ono, Y., Morimoto, R., Nozawa, Y., Gomez-Sanchez, C.E., Tomlins, S.A., Rainey, W.E., Ito, S., Satoh, F. &amp; Sasano, H. (2017)  Histopathological classification of cross-sectional image-negative hyperaldosteronism.  <i>J. Clin. Endocrinol. Metab.<\/i>, 102, 1182-1192.","DOI":"10.1210\/jc.2016-2986"},{"key":"119","doi-asserted-by":"crossref","unstructured":"Yamazaki, Y., Omata, K., Tezuka, Y., Ono, Y., Morimoto, R., Adachi, Y., Ise, K., Nakamura, Y., Gomez-Sanchez, C.E., Shibahara, Y., Kitamoto, T., Nishikawa, T., Ito, S., Satoh, F. &amp; Sasano, H. (2018)  Tumor cell subtypes based on the intracellular hormonal activity in KCNJ5-mutated aldosterone-producing adenoma.  <i>Hypertension<\/i>, 72, 632-640.","DOI":"10.1161\/HYPERTENSIONAHA.118.10907"},{"key":"120","doi-asserted-by":"crossref","unstructured":"Yoshida, M., Ma, J., Tomita, T., Morikawa, N., Tanaka, N., Masamura, K., Kawai, Y. &amp; Miyamori, I. (2005)  Mineralocorticoid receptor is overexpressed in cardiomyocytes of patients with congestive heart failure.  <i>Congest. Heart Fail.<\/i>, 11, 12-16.","DOI":"10.1111\/j.1527-5299.2005.03722.x"},{"key":"121","doi-asserted-by":"crossref","unstructured":"Young, W.F., Stanson, A.W., Thompson, G.B., Grant, C.S., Farley, D.R. &amp; van Heerden, J.A. (2004)  Role for adrenal venous sampling in primary aldosteronism.  <i>Surgery<\/i>, 136, 1227-1235.","DOI":"10.1016\/j.surg.2004.06.051"},{"key":"122","doi-asserted-by":"crossref","unstructured":"Zennaro, M.C., Boulkroun, S. &amp; Fernandes-Rosa, F. (2017)  Genetic causes of functional adrenocortical adenomas.  <i>Endocr. Rev.<\/i>, 38, 516-537.","DOI":"10.1210\/er.2017-00189"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/254\/1\/254_1\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T04:01:36Z","timestamp":1621656096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/254\/1\/254_1\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.254.1","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}